CRB
NVO

Chad R. Baker’s Novo Nordisk NVO Stock Holding History

Chad R. Baker’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-4,815
Closed -$267K – 59
2025
Q3 		$267K Hold
4,815
– – 0.05% 54
2025
Q2 		$332K Hold
4,815
– – 0.06% 50
2025
Q1 		$334K Sell
4,815
-345
-7% -$28.5K 0.07% 50
2024
Q4 		$444K Sell
5,160
-20
-0.4% -$2.16K 0.09% 49
2024
Q3 		$617K Sell
5,180
-200
-4% -$26.7K 0.12% 50
2024
Q2 		$768K Hold
5,380
– – 0.16% 48
2024
Q1 		$691K Hold
5,380
– – 0.15% 49
2023
Q4 		$557K Sell
5,380
-250
-4% -$24.7K 0.13% 49
2023
Q3 		$512K Buy
5,630
+1,040
+23% +$91.6K 0.13% 50
2023
Q2 		$371K Sell
4,590
-200
-4% -$16.3K 0.09% 49
2023
Q1 		$381K Buy
+4,790
New +$340K 0.1% 49

Other funds holding NVO

Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Chad R. Baker's NVO Position: Q4 2025 in Review

Chad R. Baker sold out of Novo Nordisk (NVO) in Q4 2025, closing a stake of 4,815 shares — an estimated $267K sold.

Chad R. Baker first reported a position in NVO in Q1 2023 and held it in 11 quarters. The position peaked at $768K in Q2 2024. 1,418 funds tracked by Wall St. Rank hold NVO as of Q4 2025.

  • Chad R. Baker reported no remaining Novo Nordisk position as of Q4 2025 after selling out during the quarter.
  • Chad R. Baker sold 4,815 Novo Nordisk shares in Q4 2025, an estimated $267K.
  • Chad R. Baker first reported a position in Novo Nordisk in Q1 2023 and held it in 11 quarters.
  • Chad R. Baker's Novo Nordisk position peaked at $768K in Q2 2024.
  • 1,418 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2025.

Based on Chad R. Baker's 13F filing for Q4 2025, filed 13 Jan 2026.